Nutritional Adequacy, Growth Trajectories, and Metabolic Health Outcomes Associated with Plant-based Diets and Alternative Milk Consumption in Toddlers

Abstract

Introduction: Background: The rising global adoption of plant-based diets (PBDs) including vegetarian (VG) and vegan (VN) patterns in the uniquely vulnerable period of toddlerhood (12–36 months) necessitates a critical assessment of their nutritional and clinical impact. This is particularly relevant given the increased replacement of traditional dairy with plant-based milk alternatives (PBMAs). Objective: To systematically synthesize and critically evaluate evidence regarding the impact of PBDs and PBMA consumption on the triad of Growth Trajectories, Nutritional Adequacy, and Metabolic Health in toddlers (12–36 months). Methods: (PRISMA-Informed): This systematic review synthesized robust evidence from cohort studies and clinical trials conducted primarily in high-income settings. The literature search spanned PubMed, Embase, Cochrane] from using a comprehensive strategy that included MESH terms for 'toddler,' 'vegan,' 'vegetarian,' 'plant-based diet,' 'growth,' and 'nutritional status.' Studies were selected based on pre-defined inclusion criteria, focusing on those reporting anthropometric data, biochemical biomarker status, and long-term metabolic outcome markers in toddlers on PBDs vs. omnivorous controls. Results: The data reveal a clinical paradox while PBDs are associated with a favorable cardiometabolic profile (significantly lower total and LDL cholesterol and reduced systemic inflammation), they also pose a risk to growth (WHO European Office for the Prevention and Control of Noncommunicable Diseases, 2021). Although the average anthropometric status is within normal limits, a statistically significant subset of toddlers (VN: 3.6%; VG: 2.4% vs. Omnivores: 0%) were classified as stunted or wasted. This vulnerability stems from the lower energy density of high-fiber foods and the use of nutritionally inferior PBMAs. Biomarker analysis consistently confirms a high prevalence of subclinical deficiencies in critical nutrients (B12, DHA, iodine, iron, and zinc), while simultaneously identifying cases of B12 hypervitaminosis due to non-standardized supplementation practices. Conclusion: The safe implementation of PBDs in toddlers is contingent upon a mandatory shift from casual adoption to rigorous, clinical management. The long-term metabolic promise is conditional upon meticulous planning, the exclusion of inadequate PBMAs, and the enforcement of precise, mandatory supplementation protocols for B12, DHA, and Vitamin D. This must be coupled with regular anthropometric and biochemical monitoring to prevent both deficiency and over-supplementation, safeguarding optimal development during this critical growth phase.